Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Molecular Cancer Therapeutics|February 1, 2017
Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances <i>In Vitro</i> and <i>In Vivo</i> Cytotoxicity in Head and Neck Squamous Cell CarcinomaLing Zeng, Reena R Beggs, Tiffiny S Cooper, et al.
Molecular Cancer Research : MCR|December 30, 2016
Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast TumorsMonica E Wielgos, Rajani Rajbhandari, Tiffiny S Cooper, et al.
Molecular and Cellular Endocrinology|February 19, 2002
Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancerEddy S Yang, Carol A Maiorino, Bernard A Roos, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
Reduction of dose delivered to organs at risk in prostate cancer patients via image-guided radiation therapyJason M Pawlowski, Eddy S Yang, Arnold W Malcolm, et al.
The Journal of Clinical Investigation|May 9, 2009
Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in miceEddy S Yang, Hong Wang, Guochun Jiang, et al.
Technology in Cancer Research & Treatment|September 20, 2007
The role of mTOR inhibition in augmenting radiation induced autophagyJerry J Jaboin, Eric T Shinohara, Luigi Moretti, et al.
Cancer Letters|May 29, 2012
Epigenetic inactivation of DNA repair in breast cancerSomaira Nowsheen, Khaled Aziz, Phuoc T Tran, et al.
Head & Neck Oncology|June 17, 2009
Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical courseFrederick Y Wu, Eddy S Yang, Christopher D Willey, et al.
Urologic Oncology|March 25, 2014
PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalationAndrew M McDonald, Rojymon Jacob, Eddy S Yang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2011
Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinomaJames A Bonner, Eddy S Yang, Hoa Q Trummell, et al.
Pageof 13